PMA device
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
Boston Scientific Corporation · Implantable Cardioverter Defibrillator (Non-Crt) (LWS, Class III) · First FDA decision Sep 28, 2012, newest May 18, 2022Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
763
Naming "Subcutaneous"
MAUDE reports
1,194
Brand "Subcutaneous", since 2015
PubMed studies
178,803
Mentioning "Subcutaneous"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
P110042-S169 · Decided May 18, 2022 · 23 days after receipt · Normal 180 Day Track No User Fee
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
5 more FDA decisions with a free account
Older decisions: P110042-S009, P110042
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)Local determinationIn effectL40056CGS Administrators, LLCUpdated Oct 30, 2026
- Incision and Drainage (I & D) of Abscess of Skin, Subcutaneous and Accessory StructuresLocal determinationIn effectL33563Wellpoint FederalUpdated Jul 14, 2026
- Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)Local determinationIn effectL40048Wellpoint FederalUpdated Jul 14, 2026
- Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)Local determinationIn effectL40050Noridian Healthcare Solutions, LLCUpdated Oct 27, 2025
- Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)Local determinationIn effectL40046Palmetto GBAUpdated Sep 5, 2025
- Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)Local determinationIn effectL36408WPS Insurance CorporationUpdated Sep 3, 2025
- Implantable Cardioverter DefibrillatorsNational analysisReview closedCAG-00157R4Updated Nov 19, 2026
- Implantable Cardioverter Defibrillators (ICDs)National determinationOn the books20.4Updated Sep 28, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Subcutaneous", any status and sponsor, newest update first.
National Cancer Institute (NCI)NIH
NCT05642195 · 30 participants (planned) · Start Nov 25, 2026 · Primary completion Dec 30, 2033
Device: Ventana PD-L1 (SP263 or SP142) assay · For: Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung and 1 more
Sites: Bethesda, Maryland
762 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Subcutaneous", and for the whole product code for context.
This brand
1,194 reports: 438 malfunction, 747 injury, 7 death
Whole product code LWS
240,687 reports: 89,252 malfunction, 148,026 injury, 3,316 death
Newest reports for this brand
2124215-2026-55196 · Received Oct 17, 2026 · Event dated Oct 2, 2026
Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
Device problem as coded: Malposition of Device; Impedance Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- EMBLEM S-ICD Pulse Generator Model A209; Subcutaneous Implantable Cardioverter DefibrillatorOpen, Classified
Z-2441-2023 · Started Jul 11, 2023 · Posted by FDA Aug 22, 2023
Reason given: There is a potential for a rare interaction between the EMBLEM S-ICD and LATITUDE communicator, which may cause S-ICD sensing disablement for a 24-hour interval.
Cause as FDA categorized it: Software design · Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
10 more recall records with a free account
Published research
The most relevant PubMed records for "Subcutaneous"[tiab]. The summary above synthesizes these.
- Subcutaneous Infusion of Fluids for Hydration or Nutrition: A Review.
Caccialanza R, Constans T, Cotogni P, et al. · JPEN J Parenter Enteral Nutr · 2018Research Support, Non-U.S. Gov't, Review
- Subcutaneous sarcoidosis.
Vainsencher D, Winkelmann RK · Arch Dermatol · 1984Case Reports
- Subcutaneous sweet syndrome.
Guhl G, García-Díez A · Dermatol Clin · 2008Review
- Spot the Pneumothorax.
Harridine J, Sovani M · Cureus · 2021Case Reports
- [Subcutaneous nodules].
Cornillier H, Ventéjou S, Bens G, et al. · Rev Med Interne · 2018
- Subcutaneous emphysema--beyond the pneumoperitoneum.
Ott DE · JSLS · 2014Review
- Subcutaneous granuloma annulare.
Requena L, Fernández-Figueras MT · Semin Cutan Med Surg · 2007Review
- Subcutaneous Emphysema after a Dental Procedure.
Brito D, Medeiros C, Caley L · Eur J Case Rep Intern Med · 2022
- Subcutaneous dermatofibroma.
Jung KD, Lee DY, Lee JH, et al. · Ann Dermatol · 2011Case Reports
- Subcutaneous xanthomatosis.
Archer CB, Sharvill DE, Smith NP · Br J Dermatol · 1990Case Reports
- Subcutaneous sarcoidosis.
Higgins EM, Salisbury JR, Du Vivier AW · Clin Exp Dermatol · 1993Case Reports
Other devices of this type
Also filed under product code LWS.
- Evera MRI XT DR SureScan Model DDMB1D4Medtronic Cardiac Rhythm Disease Management · PMA 2022
- CurrentAbbott Medical · PMA 2026
- Evera S Dr,s Vr Xt Dr, Xt Ve,icd'sMedtronic Cardiac Rhythm Disease Management · PMA 2016
- Gem III At ICDMedtronic, Inc. · PMA 2016
- EMBLEM S-ICD Electrode (Lead) Model 3501Boston Scientific Corporation · PMA 2026
- Entrust ICDMedtronic Cardiac Rhythm Disease Management · PMA 2014
- ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leadsBoston Scientific · PMA 2026
- Sprint Quattro Secure S MRI Surescan Lead Model 6935M,SPRINT Quattro Secure MRI Surescan Lead Model 6947MMedtronic, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.